• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依那普利或赖诺普利阻断转化酶后人体中血管紧张素I蓄积的缺乏。

Lack of angiotensin I accumulation after converting enzyme blockade by enalapril or lisinopril in man.

作者信息

Nussberger J, Brunner D B, Waeber B, Biollaz J, Brunner H R

出版信息

Clin Sci (Lond). 1987 Mar;72(3):387-9. doi: 10.1042/cs0720387.

DOI:10.1042/cs0720387
PMID:3028701
Abstract

In nine normal volunteers, a series of five venous blood samples was obtained before and up to 24 h after converting enzyme inhibition by a single oral dose of enalapril or lisinopril. Plasma renin activity and blood angiotensin I were measured. A close linear relationship was found between the increase in plasma renin activity and the increase in blood angiotensin I. The linear correlation between plasma renin activity and blood angiotensin I remained after converting enzyme inhibition. Thus, the rise in angiotensin I after inhibition of the conversion of angiotensin I to angiotensin II is due to an enhanced release of renin rather than to accumulation of angiotensin I.

摘要

在9名正常志愿者中,在单次口服依那普利或赖诺普利抑制转换酶之前及之后长达24小时内,采集了一系列5份静脉血样本。测量了血浆肾素活性和血中血管紧张素I。发现血浆肾素活性的增加与血中血管紧张素I的增加之间存在密切的线性关系。在转换酶抑制后,血浆肾素活性与血中血管紧张素I之间的线性相关性仍然存在。因此,在抑制血管紧张素I向血管紧张素II的转化后,血管紧张素I的升高是由于肾素释放增加而非血管紧张素I的积累所致。

相似文献

1
Lack of angiotensin I accumulation after converting enzyme blockade by enalapril or lisinopril in man.依那普利或赖诺普利阻断转化酶后人体中血管紧张素I蓄积的缺乏。
Clin Sci (Lond). 1987 Mar;72(3):387-9. doi: 10.1042/cs0720387.
2
Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers.赖诺普利和依那普利单独及与普萘洛尔联合应用对健康志愿者血浆血管紧张素转换酶活性和循环肾素的影响。
Pharmacol Toxicol. 1999 Mar;84(3):110-4. doi: 10.1111/j.1600-0773.1999.tb00884.x.
3
A comparison of lisinopril with enalapril by monitoring plasma angiotensin II levels in humans.通过监测人体血浆血管紧张素II水平对赖诺普利和依那普利进行比较。
Jpn J Pharmacol. 1990 Oct;54(2):143-9. doi: 10.1254/jjp.54.143.
4
Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure.赖诺普利(MK - 521)对充血性心力衰竭的急性血流动力学和激素影响
Am Heart J. 1986 Jul;112(1):121-9. doi: 10.1016/0002-8703(86)90689-7.
5
Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes.血管紧张素转换酶(ACE)抑制剂赖诺普利使充血性心力衰竭患者血管活性肠肽(VIP)增加。与血流动力学和激素变化的关系。
Gen Pharmacol. 1987;18(6):577-87. doi: 10.1016/0306-3623(87)90027-9.
6
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.口服活性肾素抑制剂阿利吉仑(SPP100)对人体血管紧张素II的抑制作用:与依那普利的比较。
Hypertension. 2002 Jan;39(1):E1-8. doi: 10.1161/hy0102.102293.
7
Additive effects of losartan and enalapril on blood pressure and plasma active renin.氯沙坦和依那普利对血压及血浆活性肾素的相加作用。
Hypertension. 1997 Feb;29(2):634-40. doi: 10.1161/01.hyp.29.2.634.
8
Measurement of angiotensin converting enzyme induction and inhibition using quantitative in vitro autoradiography: tissue selective induction after chronic lisinopril treatment.使用定量体外放射自显影法测量血管紧张素转换酶的诱导和抑制:赖诺普利长期治疗后的组织选择性诱导
J Hypertens. 1991 Jul;9(7):579-87. doi: 10.1097/00004872-199107000-00001.
9
Investigation of the biochemical effects of renin inhibition in normal volunteers treated by an ACE inhibitor.血管紧张素转换酶抑制剂治疗的正常志愿者中肾素抑制的生化效应研究。
Br J Clin Pharmacol. 1992 Mar;33(3):253-60. doi: 10.1111/j.1365-2125.1992.tb04032.x.
10
Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic rats.血管紧张素转换酶抑制剂赖诺普利对正常大鼠和糖尿病大鼠的影响。
J Hypertens. 1988 Aug;6(8):677-83. doi: 10.1097/00004872-198808000-00012.

引用本文的文献

1
Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.赖诺普利。对其药效学和药代动力学特性以及在高血压和充血性心力衰竭中的治疗用途的初步综述。
Drugs. 1988 Jun;35(6):646-69. doi: 10.2165/00003495-198835060-00003.
2
The effect of saturation of ACE binding sites on the pharmacokinetics of enalaprilat in man.血管紧张素转换酶(ACE)结合位点饱和对依那普利拉人体药代动力学的影响。
Br J Clin Pharmacol. 1992 Feb;33(2):155-60. doi: 10.1111/j.1365-2125.1992.tb04018.x.